1. Home
  2. KALV vs TRST Comparison

KALV vs TRST Comparison

Compare KALV & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

N/A

Current Price

$15.64

Market Cap

757.7M

Sector

Health Care

ML Signal

N/A

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

N/A

Current Price

$45.00

Market Cap

782.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
KALV
TRST
Founded
N/A
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
757.7M
782.5M
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
KALV
TRST
Price
$15.64
$45.00
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$30.00
N/A
AVG Volume (30 Days)
564.9K
107.5K
Earning Date
04-13-2026
04-22-2026
Dividend Yield
N/A
3.38%
EPS Growth
N/A
N/A
EPS
N/A
2.41
Revenue
$50,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$108.37
N/A
P/E Ratio
N/A
$18.68
Revenue Growth
495.66
N/A
52 Week Low
$9.83
$27.18
52 Week High
$19.00
$48.45

Technical Indicators

Market Signals
Indicator
KALV
TRST
Relative Strength Index (RSI) 53.36 52.47
Support Level $14.45 $44.65
Resistance Level $16.33 $45.27
Average True Range (ATR) 0.69 1.12
MACD 0.07 -0.17
Stochastic Oscillator 80.05 41.88

Price Performance

Historical Comparison
KALV
TRST

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

Share on Social Networks: